Range
29.81 - 30.53
Vol / Avg.
753.4K/925.2K
Div / Yield
-
52 Wk
29.01 - 64.37
Mkt Cap
4.3B
Payout Ratio
-
Open
30.2
P/E
-
EPS
-0.57
Shares
141.1M
Outstanding
141.1M
Total Float
119.1M
load more
Sector: Health Care.Industry: Biotechnology
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy. Ionis subsequently brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-03
REV
Q2 2021Est.ActualSurprise
EPS-0.580-0.260 0.3200
REV129.940M126.000M-3.940M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Ionis Pharmaceuticals Questions & Anwsers

Q

How do I buy Ionis Pharmaceuticals (IONS) stock?

A

You can purchase shares of Ionis Pharmaceuticals (NASDAQ: IONS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ionis Pharmaceuticals's (IONS) competitors?

Q

What is the target price for Ionis Pharmaceuticals (IONS) stock?

A

The latest price target for Ionis Pharmaceuticals (NASDAQ: IONS) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 31.00 expecting IONS to rise to within 12 months (a possible 1.84% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Ionis Pharmaceuticals (IONS)?

A

The stock price for Ionis Pharmaceuticals (NASDAQ: IONS) is $30.44 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Ionis Pharmaceuticals (IONS) pay a dividend?

A

There are no upcoming dividends for Ionis Pharmaceuticals.

Q

When is Ionis Pharmaceuticals (NASDAQ:IONS) reporting earnings?

A

Ionis Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 3, 2021.

Q

Is Ionis Pharmaceuticals (IONS) going to split?

A

There is no upcoming split for Ionis Pharmaceuticals.

Q

What sector and industry does Ionis Pharmaceuticals (IONS) operate in?

A

Ionis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.